Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05028751 |
Title | A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Kronos Bio |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California Los Angeles (UCLA) | Recruiting | Los Angeles | California | 990095 | United States | Details |
The Blood and Marrow Transplant Group of Georgia | Recruiting | Atlanta | Georgia | 30342 | United States | Details |
University of Chicago Medical Center | Recruiting | Chicago | Illinois | 60637 | United States | Details |
Memorial Sloan Kettering Cancer Center | Recruiting | New York | New York | 10065 | United States | Details |
Oregon Health and Science University | Recruiting | Portland | Oregon | 97239 | United States | Details |
Texas Oncology - Baylor Charles A. Sammons Cancer Center | Completed | Dallas | Texas | 75246 | United States | Details |
Froedtert Hospital | Recruiting | Milwaukee | Wisconsin | 53226 | United States | Details |
Hospital San Pedro de Alcantara | Not yet recruiting | Cáceres | 10001 | Spain | Details |